ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

IMVTW Immunovant Inc

6.86
0.00 (0.00%)
Last Updated: 18:00:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 5.06
Ask Price 4,294.67
News -
Share Name Share Symbol Market Stock Type
Immunovant Inc IMVTW NASDAQ Equity Warrant
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 6.86 18:00:00
Open Price Low Price High Price Close Price Previous Close
6.86
Trades Shares Traded Average Volume
0 0 -
Last Trade Type Quantity Price Currency
- 0  6.86 USD

Immunovant Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
996.71M 145.29M - 0 -259.34M -1.78 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Immunovant

Real-Time news about Immunovant Inc (NASDAQ): 0 recent articles
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No IMVTW Message Board. Create One! See More Posts on IMVTW Message Board See More Message Board Posts

IMVTW Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes IMVT-1401 targets the neonatal Fc receptor (FcRn).